Open access
Open access
Powered by Google Translator Translator

Post-trial follow-up | Metastasis-directed therapy vs. observation in oligometastatic prostate cancer.

18 Oct, 2022 | 12:47h | UTC

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials – Journal of Clinical Oncology

Commentary: Metastasis-Directed Therapy for Prostate Cancer Found Beneficial Long-Term – Cancer Therapy Advisor

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.